Our colorectal cancer nomograms are online prediction tools that are designed to help physicians and patients make decisions about treatment and long-term follow-up care. They may also be used by researchers to help design and evaluate clinical trials.
Doctors and researchers at Memorial Sloan-Kettering have created two nomograms that are customized for people with colorectal cancer:
If you are a patient, we recommend that you use these tools only in consultation with your healthcare provider.
These nomograms are appropriate for patients who have undergone surgery for colon cancer, assuming that all of the primary cancer was completely removed during the original surgery. They are designed for patients with localized colon cancer that shows no evidence of metastasis, or spread beyond the colon, before or at the time of surgery.
These tools are only appropriate for patients with tumors found in the colon — between the pouch that forms the first part of the large intestine (known as the cecum) and the S-shaped section of the colon that connects to the rectum (the rectosigmoid, or sigmoid colon). Patients using these nomograms may or may not have had chemotherapy.
Our disease-free probability nomogram can be used to predict the probability that a patient will be disease-free from colon cancer five to ten years following complete resection, or surgical removal of all cancerous tissue.
This tool is based on a database of 1,320 patients with nonmetastatic colon cancer treated at Memorial Sloan-Kettering Cancer Center. It provides a more accurate picture of the five- or ten-year risk of recurrence than older assessment tools, such as the staging system of the American Joint Committee on Cancer.
You will need the following information to use this nomogram:
If you are a patient, we recommend that you use this tool only in consultation with your healthcare provider.
This colon cancer nomogram can be used to predict the probability of surviving at least five years following complete resection (surgical removal) of all cancerous tissue. The tool also provides a highly likely range for the probability of survival, known as the 95 percent confidence interval.
This tool is based on records from 128,853 primary colon cancer patients reported to the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. This nomogram provides a more accurate picture of overall survival at five years than the American Joint Committee on Cancer staging system.
This nomogram can be used to create three different estimates of varying accuracy, based on the amount of data included.
For a basic estimate of overall survival probability, you will need the following information:
For a more accurate estimate, you will need:
For the most accurate estimate, you will need:
If you are a patient, we recommend that you use this tool only in consultation with your healthcare provider.
If you have questions or comments about these prediction tools, please contact us at nomograms@mskcc.org.
Use our colorectal cancer nomograms.